Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis

Royal Prince Alfred Hospital, Sydney

Universitätsklinikum Schleswig-Holstein Zentralklinikum, Lübeck Medizinische Klinik III, Pneumologie, Lübeck

University of Florida, Gainesville

Yedikule Pulmonary Diseases and Pulmonary Surgery Training and Research Hospital, Istanbul

Cincinnati Children's Hospital Medical Center, Cincinnati

Asklepios Fachkliniken München - Gauting, Gauting

UCLA, Los Angeles

Aarhus University Hospital, Aarhus

CHU Rennes Hospital Pontchaillou, Rennes

Westdeutsches Lungenzentrum am Universitätsklinikum Essen, Essen

Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg

Attikon University Hospital, Athens

Rabin Medical Center, Petah Tikva

IRCCS Policlinico San Matteo, Pavia

Niigata University Medical and Dental Hospital, Niigata

National Hospital Organization Kinki-Chuo, Osaka

Tohoku University Hospital, Sendai

Aichi Medical University Hospital, Toyohashi

Kanagawa Cardiovascular and Respiratory Center, Yokohama

St. Antonius Hospital, Nieuwegein

Hospital de dia de Pneumologia, Lisbon

City Hospital St. Petersburg, Saint Petersburg

Centre Hospitalier Universitaire Vaudois, Lausanne

Royal Brompton Hospital, London

Hospital Sao Joao, Porto

II. Pulmonary Department National Institut for TB, Lung Diseases and Chest Surgery, Vyšné Hágy

Seoul National University Hospital, Seoul

Asan Medical Center, Division of Pulmonary and Critical Care Medicine, Seoul

Samsung Medical Center, Division of Pulmonary and Critical Care Medicine, Seoul

Hospital University de Bellvitge (HUB), Barcelona